[go: up one dir, main page]

MX9206981A - Vacunas de recombinantes y metodo para producirlas. - Google Patents

Vacunas de recombinantes y metodo para producirlas.

Info

Publication number
MX9206981A
MX9206981A MX9206981A MX9206981A MX9206981A MX 9206981 A MX9206981 A MX 9206981A MX 9206981 A MX9206981 A MX 9206981A MX 9206981 A MX9206981 A MX 9206981A MX 9206981 A MX9206981 A MX 9206981A
Authority
MX
Mexico
Prior art keywords
replication
nucleic acid
producing
recombinant vaccines
competent recombinant
Prior art date
Application number
MX9206981A
Other languages
English (en)
Inventor
Reilly Patricia Anne
Feinberg Mark
Andino Raul
Weeks-Levy Carolyn Louise
Original Assignee
Whitehead Biomedical Inst
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Whitehead Biomedical Inst, American Cyanamid Co filed Critical Whitehead Biomedical Inst
Publication of MX9206981A publication Critical patent/MX9206981A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Virus recombinantes competentes en replicación, en particular, poliovirus recombinantes competentes en replicación que incluyen secuencias de ácido nucleico exógenas que codifican un polipéptido exógeno y una secuencia de ácido nucleico que codifica un lugar de escisión proteolítica artificial para una proteasa vírica o celular que procesa proteolíticamente (escinde) la proteína precursora producida por el virus progenitor y hace uso de la misma.
MX9206981A 1991-12-06 1992-12-03 Vacunas de recombinantes y metodo para producirlas. MX9206981A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80489391A 1991-12-06 1991-12-06
US94779092A 1992-09-18 1992-09-18

Publications (1)

Publication Number Publication Date
MX9206981A true MX9206981A (es) 1994-08-31

Family

ID=27122734

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9206981A MX9206981A (es) 1991-12-06 1992-12-03 Vacunas de recombinantes y metodo para producirlas.

Country Status (20)

Country Link
EP (1) EP0672157B1 (es)
JP (1) JPH07502403A (es)
KR (1) KR100272419B1 (es)
CN (1) CN1055726C (es)
AT (1) ATE206762T1 (es)
AU (1) AU674134B2 (es)
CA (1) CA2123804A1 (es)
CZ (1) CZ127394A3 (es)
DE (1) DE69232122T2 (es)
DK (1) DK0672157T3 (es)
ES (1) ES2163405T3 (es)
FI (1) FI942623L (es)
HU (1) HUT67346A (es)
IL (1) IL104003A0 (es)
MX (1) MX9206981A (es)
NO (1) NO942075L (es)
NZ (1) NZ246276A (es)
PT (1) PT672157E (es)
TW (1) TW403784B (es)
WO (1) WO1993011251A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997012048A1 (en) * 1995-09-27 1997-04-03 Medical Research Council Recombinant viruses incorporating a protease cleavable protein
FI20075063A0 (fi) 2007-02-01 2007-02-01 Vactech Oy Allergisen herkistymisen estäminen
MX2020009720A (es) 2018-03-19 2021-01-08 Boehringer Ingelheim Vetmedica China Co Ltd Virus recombinante capaz de expresar de manera estable proteinas objetivo.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1293591C (en) * 1985-01-11 1991-12-24 Charles A. Kettner Peptide substrates for detecting virus-specified protease activity
ES2059482T3 (es) * 1987-12-23 1994-11-16 Boehringer Ingelheim Int Expresion de la proteasa p2a de hrv2 codificada por virus.
CA1340378C (en) * 1988-02-26 1999-02-02 Laurence K. Grill Non-nuclear chromosomal transformation
DD275259A1 (de) * 1988-08-30 1990-01-17 Akad Wissenschaften Ddr Verfahren zur konstruktion eines neuen expressionsvektors
WO1990011359A1 (en) * 1989-03-20 1990-10-04 Whitehead Institute For Biomedical Research Intracellular method of inhibiting hiv in mammalian cells
GB8912496D0 (en) * 1989-05-31 1989-07-19 Medical Res Council Vaccines
EP0478588A1 (en) * 1989-05-31 1992-04-08 Medical Research Council Poliovirus chimaeras
ATE177786T1 (de) * 1990-05-28 1999-04-15 Univ Osaka Res Found Herstellungsverfahren für ein plasmid mit fähigkeiten zu expression und prozessierung nach translation eines retroviralen gens, so erhaltenes plasmid und dessen expressionsprodukt
CA2072154A1 (en) * 1990-08-28 1992-03-01 Wolfgang Sommergruber Test system for checking the activity of viral proteinases

Also Published As

Publication number Publication date
FI942623L (fi) 1994-07-21
KR100272419B1 (ko) 2001-02-01
ATE206762T1 (de) 2001-10-15
CN1055726C (zh) 2000-08-23
AU674134B2 (en) 1996-12-12
PT672157E (pt) 2002-04-29
DK0672157T3 (da) 2001-12-03
KR950700421A (ko) 1995-01-16
DE69232122T2 (de) 2002-05-16
FI942623A0 (fi) 1994-06-03
WO1993011251A1 (en) 1993-06-10
HUT67346A (en) 1995-03-28
DE69232122D1 (de) 2001-11-15
JPH07502403A (ja) 1995-03-16
NZ246276A (en) 1996-08-27
ES2163405T3 (es) 2002-02-01
AU3242493A (en) 1993-06-28
EP0672157B1 (en) 2001-10-10
IL104003A0 (en) 1993-05-13
CA2123804A1 (en) 1993-06-10
CN1075334A (zh) 1993-08-18
TW403784B (en) 2000-09-01
NO942075D0 (no) 1994-06-03
CZ127394A3 (en) 1995-11-15
HU9401689D0 (en) 1994-09-28
NO942075L (no) 1994-08-03
EP0672157A1 (en) 1995-09-20

Similar Documents

Publication Publication Date Title
DE69033425D1 (de) HCV-Isolat J-1
DE69839557D1 (de) Klonierte genome von infektiösen hepatitis c viren und deren verwendungen
DK0484787T3 (da) HCV-specifikke peptider, fremgangsmåde til opnåelse deraf og anvendelse deraf
NO20043419L (no) Nytt cytokin, zcytor17-ligand
ES2059565T3 (es) Virus mva de la vacuna, recombinante.
DK0561890T3 (da) DNA ekspressionssystemer baseret på alphavira
MX9206981A (es) Vacunas de recombinantes y metodo para producirlas.
DK1501936T3 (da) Familie af cytokin-proteiner
DE69013471D1 (de) Methode zur Stabilisierung von rekombinanten Hepatitis-B-Virus-Oberflächenproteinen aus Hefe.
AR009365A1 (es) Vacunas del virus de la fiebre aftosa (fmdv), peptidos, secuencias de adn y el uso de los peptidos en sistemas de deteccion y el uso de la vacuna fmdc para la preparacion de una composicion para inmunizar cerdos y ganado vacuno
AR036793A1 (es) Vacunas de acido nucleico que utilizan acidos nucleicos que codifican un antigeno de tumor con un acido nucleico que codifica una citoquina como adyuvante
AU5322800A (en) Cloned genone of infectious hepatitis c virus of genotype 2a and uses thereof
EP0236977A3 (en) Bovine virus diarrhea and hog cholera vaccines
AU590861B2 (en) New human lymphotoxin (TNF-beta) polypeptides their prepartion and use
ATE122055T1 (de) Dna- und rna-moleküle des westlichen subtyps des fsme-virus, polypeptide, die von diesen molekülen codiert werden, und deren verwendung.
ATE132160T1 (de) Verfahren zur reinigung von aussenmembran-protein von haemophilus influenza
RU94030478A (ru) Рекомбинантный вирус, способ его получения, способ иммунизации, способ получения протеина, вакцинная композиция, применение рекомбинантного вируса
AR248047A1 (es) Procedimiento para la preparacion de una vacuna a base de virus del herpes bovina modificado tipo 1.
FI870501A0 (fi) Menetelmä melanoomaan liittyvän p97-antigeenin antigeenisen sukulaispeptidin tai -proteiinin valmistamiseksi, sekä siinä käyttökelpoiset yhdistelmävirukset, yhdistelmävektorit ja isäntäsolut
EP0945512A3 (en) Novel serine proteases
KR830010193A (ko) 바실러스 클로닝 매개체, 재결합 dna분자 그것들과 함께 변형된 간균 숙주 그리고 이종(異知) dna배열의 표현 방법과 그것으로 이루어진 폴리펩타이드의 생성방법
MX172696B (es) Nuevos antigenos y metodo para su produccion